(Q39791889)

14 September 2017

title

Effect of memantine on resting state default mode network activity in Alzheimer's disease (English)

1 reference

14 September 2017

0 references

12

1 reference

14 September 2017

Sandra Rosini

9

0 references

Marco Lorenzi

Marco Lorenzi

1

0 references

Francesca B. Pizzini

Francesca B Pizzini

6

0 references

Elisa Canu

Elisa Canu

4

0 references

Maria Cotelli

Maria Cotelli

8

0 references

Nicola B. Mercuri

Nicola B Mercuri

3

0 references

Carlo Caltagirone

11

Carlo Caltagirone

1 reference

14 September 2017

Alberto Beltramello

2

1 reference

14 September 2017

Giada Zoccatelli

5

1 reference

14 September 2017

Franco Alessandrini

7

1 reference

14 September 2017

Daniela Costardi

10

1 reference

14 September 2017

publication date

1 March 2011

1 reference

14 September 2017

1 reference

14 September 2017

volume

28

1 reference

14 September 2017

issue

3

1 reference

14 September 2017

page(s)

205-217

1 reference

https://scigraph.springernature.com/pub.10.2165/11586440-000000000-00000

14 September 2017

exact match

0 references

cites work

Long-term effects of the concomitant use of memantine with cholinesterase inhibition in Alzheimer disease

1 reference

https://api.crossref.org/works/10.2165%2F11586440-000000000-00000

Memantine treatment in mild to moderate Alzheimer disease: a 24-week randomized, controlled trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11586440-000000000-00000

Memantine treatment in patients with moderate to severe Alzheimer disease already receiving donepezil: a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11586440-000000000-00000

Longitudinal multimodal imaging in mild to moderate Alzheimer disease: a pilot study with memantine

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11586440-000000000-00000

Memantine: a NMDA receptor antagonist that improves memory by restoration of homeostasis in the glutamatergic system--too little activation is bad, too much is even worse

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11586440-000000000-00000

Memantine agonist action at dopamine D2High receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11586440-000000000-00000

Memantine inhibits ATP-dependent K+ conductances in dopamine neurons of the rat substantia nigra pars compacta.

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11586440-000000000-00000

Dopamine transporter imaging in adult patients with attention-deficit/hyperactivity disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11586440-000000000-00000

Contraction of time in attention-deficit hyperactivity disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11586440-000000000-00000

Visual hallucinations and agitation in Alzheimer's disease due to memantine: report of three cases.

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11586440-000000000-00000

Spontaneous fluctuations in brain activity observed with functional magnetic resonance imaging

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11586440-000000000-00000

How default is the default mode of brain function? Further evidence from intrinsic BOLD signal fluctuations.

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11586440-000000000-00000

Medial prefrontal cortex and self-referential mental activity: relation to a default mode of brain function

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11586440-000000000-00000

Default-mode brain dysfunction in mental disorders: A systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11586440-000000000-00000

Altered resting state networks in mild cognitive impairment and mild Alzheimer's disease: an fMRI study.

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11586440-000000000-00000

Regional homogeneity, functional connectivity and imaging markers of Alzheimer's disease: a review of resting-state fMRI studies.

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11586440-000000000-00000

Default-mode network activity distinguishes Alzheimer's disease from healthy aging: evidence from functional MRI

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11586440-000000000-00000

Molecular, structural, and functional characterization of Alzheimer's disease: evidence for a relationship between default activity, amyloid, and memory

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11586440-000000000-00000

The CONSORT statement: revised recommendations for improving the quality of reports of parallel-group randomised trials

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11586440-000000000-00000

The revised CONSORT statement for reporting randomized trials: explanation and elaboration

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11586440-000000000-00000

Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11586440-000000000-00000

The Clinical Dementia Rating (CDR): current version and scoring rules

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11586440-000000000-00000

Pathological verification of ischemic score in differentiation of dementias.

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11586440-000000000-00000

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11586440-000000000-00000

Claustrophobia and premature termination of magnetic resonance imaging examinations.

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11586440-000000000-00000

A method for making group inferences from functional MRI data using independent component analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11586440-000000000-00000

Performance of blind source separation algorithms for fMRI analysis using a group ICA method

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11586440-000000000-00000

An automated method for neuroanatomic and cytoarchitectonic atlas-based interrogation of fMRI data sets

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11586440-000000000-00000

Age as risk factor for sporadic dementia of the Alzheimer type?

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11586440-000000000-00000

Mechanism of action of memantine

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11586440-000000000-00000

Localized in vivo 13C-NMR of glutamate metabolism in the human brain: initial results at 4 tesla.

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11586440-000000000-00000

Determination of the rate of the glutamate/glutamine cycle in the human brain by in vivo 13C NMR.

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11586440-000000000-00000

Stoichiometric coupling of brain glucose metabolism and glutamatergic neuronal activity

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11586440-000000000-00000

A coherent neurobiological framework for functional neuroimaging provided by a model integrating compartmentalized energy metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11586440-000000000-00000

Cellular mechanisms of brain energy metabolism and their relevance to functional brain imaging.

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11586440-000000000-00000

Reduced glutamate neurotransmission in patients with Alzheimer's disease -- an in vivo (13)C magnetic resonance spectroscopy study.

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11586440-000000000-00000

The inhibitory effects of beta-amyloid on glutamate and glucose uptakes by cultured astrocytes.

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11586440-000000000-00000

Metabolic reduction in the posterior cingulate cortex in very early Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11586440-000000000-00000

Involvement of the sigma 1 receptor in the modulation of dopaminergic transmission by amantadine

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11586440-000000000-00000

Memantine upregulates BDNF and prevents dopamine deficits in SIV-infected macaques: a novel pharmacological action of memantine.

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11586440-000000000-00000

Efficiency and cost of economical brain functional networks.

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11586440-000000000-00000

Decreased dopamine D4 receptor expression increases extracellular glutamate and alters its regulation in mouse striatum

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11586440-000000000-00000

Effects of NMDA receptor antagonists on D1 dopamine receptor-mediated changes in striatal immediate early gene expression: evidence for involvement of pharmacologically distinct NMDA receptors?

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11586440-000000000-00000

GABA concentrations in the human anterior cingulate cortex predict negative BOLD responses in fMRI.

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11586440-000000000-00000

Memantine treatment reduces the expression of the K(+)/Cl(-) cotransporter KCC2 in the hippocampus and cerebral cortex, and attenuates behavioural responses mediated by GABA(A) receptor activation in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11586440-000000000-00000

Memantine protects rat cortical cultured neurons against beta-amyloid-induced toxicity by attenuating tau phosphorylation

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11586440-000000000-00000

The clinical use of structural MRI in Alzheimer disease

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11586440-000000000-00000

Amphetamine and dopamine-induced immediate early gene expression in striatal neurons depends on postsynaptic NMDA receptors and calcium.

21 January 2018

1 reference

12 December 2020

beta-Amyloid selectively augments NMDA receptor-mediated synaptic transmission in rat hippocampus.

1 reference

12 December 2020

The Neuropsychiatric Inventory: comprehensive assessment of psychopathology in dementia

1 reference

12 December 2020

Glutamate release from microglia via glutamate transporter is enhanced by amyloid-beta peptide

1 reference

12 December 2020

Neurochemical changes in the cerebral cortex of treated and untreated hydrocephalic rat pups quantified with in vitro 1H-NMR spectroscopy.

1 reference

12 December 2020

Memantine treatment in patients with mild to moderate Alzheimer's disease: results of a randomised, double-blind, placebo-controlled 6-month study.

1 reference

12 December 2020

Memantine for dementia

1 reference

12 December 2020

Astrocytes Couple Synaptic Activity to Glucose Utilization in the Brain.

1 reference

12 December 2020

10.2165/11586440-000000000-00000

Identifiers

DOI

1 reference

Dimensions Publication ID

14 September 2017

1033723175

0 references

1 reference